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DEPARTMENT OF MANAGED HEALTH CARE 
Director: Shelley Rouillard ⧫ (916) 324-8176 ⧫ Help Center: (888)466-2219 or 
www.HealthHelp.ca.gov Internet: www.dmhc.ca.gov  
 
reated on July 1, 2000, the Department of Managed Health Care (DMHC) 
regulates the managed health care industry in California. The creation of 
DMHC resulted from Governor Gray Davis’s approval of AB 78 (Gallegos) 
(Chapter 525, Statutes of 1999), a bill that reformed the regulation of managed care in the state. 
DMHC is created in Health and Safety Code section 1341; DMHC’s regulations are codified in 
Title 28 of the California Code of Regulations (CCR). 
DMHC administers the Knox-Keene Health Care Service Plan Act of 1975, Health and 
Safety Code section 1340 et seq., which is intended to promote the delivery of health and medical 
care to Californians who enroll in services provided by a health care service plan. A “health care 
service plan” (health plan)—more commonly known as a health maintenance organization (HMO) 
or managed care organization (MCO)—is defined broadly as any person who undertakes to arrange 
for the provision of health care services to enrollees, or to pay for or reimburse any part of the cost 
for those services, in return for a prepaid or periodic charge paid by or on behalf of enrollees. 
In Health and Safety Code section 1342, the legislature has expressly instructed the DMHC 
Director to ensure the continued role of the professional as the determiner of the patient’s health 
needs; ensure that enrollees1 are educated and informed of the benefits and services available in 
and increase consumer choice in the healthcare market; and promote effective representation of 
the interests of enrollees, including ensuring the best possible health care at the lowest possible 
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cost by transferring the financial risk of health care from patients to providers. The DMHC Director 
must also prosecute individuals and/or health plans who engage in fraud or misrepresent or deceive 
consumers; and ensure the financial stability of health plans through proper regulation. Health care 
must be accessible to enrollees and rendered in a manner to provide continuity of care, which 
includes a grievance process that is expeditious and thoroughly reviewed by DMHC. 
The Director of DMHC is appointed by, and serves at the pleasure of, the Governor. 
DMHC’s staff of attorneys, financial examiners, health plan analysts, physicians, health care 
professionals, consumer service representatives, and support staff assist the DMHC Director in 
licensing and regulating more than 130 health plans in California. Licensed health plans include 
HMOs and other full-service health plans, as well as several categories of specialized health plans 
such as prepaid dental, vision, mental health, chiropractic, and pharmacy plans. DMHC-licensed 
health plans provide health care services to approximately 26 million California enrollees. 
Created in Health and Safety Code section 1374.30 et seq., DMHC’s independent medical 
review (IMR) system allows health plan enrollees to seek an independent review when medical 
services are denied, delayed, or otherwise limited by a plan or one of its contracting providers, 
based on a finding that the service is not medically necessary or appropriate. The independent 
reviews are conducted by expert medical organizations that are independent of the health plans 
and certified by an accrediting organization. An IMR determination is binding on the health plan, 
and DMHC will enforce it. 
SB 260 (Speier) (Chapter 529, Statutes of 1999) added section 1347.15 to the Health and 
Safety Code to create the Financial Solvency Standards Board (FSSB). Comprised of the DMHC 
Director and seven members appointed by the Director, FSSB periodically monitors and reports 
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on the implementation and results of those requirements and standards, and reviews proposed 
regulatory changes. FSSB advises the DMHC Director on matters of financial solvency affecting 
the delivery of health care services. FSSB develops and recommends financial solvency 
requirements and standards relating to plan operations. 
DMHC houses the Help Center, which is open 24 hours a day, 365 days a year, and 
functions in many languages to help consumers who experience problems with their health plan. 
The Help Center educates consumers about their health care rights; resolves consumer complaints; 
helps consumers navigate and understand their coverage; and ensures access to appropriate health 
care services. The DMHC Help Center provides direct assistance to health care consumers through 
a call center and online access. DMHC is funded by assessments on its regulated health plans.  
MAJOR PROJECTS 
DMHC Releases 2018 Annual Report 
In May of 2019, DMHC issued its 2018 Annual Report, which includes an enrollment 
overview, statistics on the Help Center, and information on plan licensing, plan monitoring, 
financial oversight, rate review, and enforcement against health plans. The annual report also 
contains two separate appendices: one summarizing the year’s consumer complaints and the other 
an independent medical review summary.  
Enrollment Overview. In addition to the 78 full-service health plans, DMHC oversees 47 
specialized health plans including chiropractic, dental, vision, psychological (behavioral health) 
and pharmacy. DMHC is now more evenly distributed between commercial and government 
enrollment with approximately 13.4 million commercial enrollees and 12.8 million government 
enrollees. DMHC licenses and regulates the full scope of managed care models, including all 
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Health Maintenance Organizations (HMO) in the state, as well as Preferred Provider Organizations 
(PPO), Exclusive Provider Organizations (EPO), Point-of-Service (POS) products and Medi-Cal 
managed care plans. They also license and conduct financial reviews of Medicare Advantage and 
Part D plans. 
Help Center Statistics. In 2018, the DMHC Help Center assisted 142,294 health care 
consumers, handled 11,464 complaints, handled 7,199 provider complaints and closed 3,693 
independent medical review cases. The Help Center also fielded 125,462 telephone inquiries and 
recovered $3.6 million for consumers and $11.9 million in provider payments. The DMHC Help 
Center continued to address the practice of “surprise balance billing” by launching an Independent 
Dispute Resolution Process (IDRP) in compliance with AB 72 (Bonta) (Chapter 492, Statutes of 
2016). In 2018, the DMHC received 39 IDRP applications and of those, 37 were ineligible or 
withdrawn, and the remaining two were still pending as of December 31, 2018. Also, in 2018, the 
DMHC Help Center launched a new Customer Relations Management (CRM) database called 
“Spotlight.” This interface is used to work on consumer cases with improved convenience and 
efficiency for both DMHC and health plans. 
Plan Licensing. DMHC issues licenses to health plans in California and reviews health 
plan mergers to ensure adherence with the Knox-Keene Act’s consumer protection and financial 
solvency requirements. DMHC reviews all aspects of a health plan’s operations, including benefits 
and coverage, template contracts with doctors and hospitals, provider networks, and complaint and 
grievance systems. After licensure, DMHC continues to monitor health plans and any changes they 
make to their operations. In 2018, DMHC plan licensing issued four new licenses, reviewed 4,329 
evidences of coverage, 1,342 advertisements, 45 Covered California filings reviews, and received 
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214 material modifications (significant changes). The Department also issued twenty All Plan 
Letters in 2018 on various topics. DMHC approved CVS’s acquisition of Aetna, Inc. [24:2 CRLR 
22–23], Optum, Inc's acquisition of DaVita Health Plan of California [24:2 CRLR 20–22], and 
Cigna Corporation’s acquisition of Express Scripts [24:2 CRLR 23–24]. In compliance with SB 
137 (Hernandez) (Chapter 649, Statutes of 2015), which became effective January 1, 2018, DMHC 
also established comprehensive requirements to ensure health plans publish and maintain accurate, 
complete and up-to-date provider directories. All health plans must have publicly available 
provider directories on their websites, make weekly updates to those directories, and provide 
consumers with simple ways to report directory errors. 
Plan Monitoring. DMHC assesses and monitors health plan networks and accessibility of 
services to enrollees, provider-to-patient ratios, and compliance with its timely access to health 
care regulations. During 2018, DMHC reports that it conducted 20 routine surveys and 35 follow-
up surveys. The surveys examine health plan practices related to access, utilization management, 
quality improvement, continuity and coordination of care, language access, and enrollee 
grievances and appeals. In 2018, DMHC held biweekly workgroups with health plans and the 
California Association of Health Plans to discuss data challenges and how to improve the 
mandatory methodology. DMHC will continue to work with health plans, providers, consumer 
advocates, and other stakeholders, to improve the usability of the timely access data and develop 
an acceptable rate of compliance. The December 2018 Timely Access Report is available on 
DMHC’s website.  
Financial Oversight. DMHC monitors the financial status of health plans and provider 
groups to make sure they can meet their financial obligations to consumers and other purchasers. 
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During 2018, DMHC conducted 67 financial examinations, reviewed 2,497 financial statements, 
ensured rebates of $72 million to consumers whose plans failed to comply with established medical 
loss ratios, remediated $1.9 million worth of disputed payments, and assessed $314,162 in interest 
and penalties. In 2018, DMHC required two full-service health plans to issue rebate checks to 
small employers for failing to meet the minimum medical loss ratio requirement of 80% in the 
small group market for 2017. In April 2018, DMHC launched an internal dashboard to provide 
staff with easy access to financial data in one centralized application, and to improve efficiencies 
in reviewing health plan and risk-bearing organizations’ financial statements and filings. 
Rate Review. In 2018, DMHC reviewed 51 individual and small group rate filings. 
Although DMHC is not authorized to approve or deny rate increases, its rate review efforts hold 
health plans accountable through transparency. On February 7, 2018, DMHC held a public meeting 
to discuss the large group aggregate rate data filed by health plans in 2017. In December 2018, 
DMHC released the first annual report summarizing this data and the impact of prescription drug 
costs on health care premiums.  
Enforcement. DMHC monitors and takes timely action against health plans that violate 
the law. In 2018, DMHC opened 1,185 cases, closed 215 of those with a penalty, and assessed 
$2,975,500 in fines and penalties against health plans. For example, DMHC imposed a penalty of 
$45,000 against Aetna Health of California, Inc. for numerous violations related to two different 
medication requests for the same enrollee. DMHC also imposed a penalty of $100,000 against 
Molina Healthcare of California, Inc. for failing to pay for covered emergency services and 
repeatedly failing to adequately consider and rectify an enrollee’s grievances. DMHC imposed a 
penalty of $70,000 against Anthem Blue Cross for untrue, misleading advertising and fraudulent, 
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dishonest dealing. Finally, the Superior Court upheld DMHC’s imposition of a $50,000 
administrative penalty against Anthem Blue Cross for delaying the Independent Medical Review 
process. 
Agreement with Anthem Blue Cross  
On June 5, 2019, DMHC and Anthem Blue Cross reached a stipulated settlement 
agreement in an enforcement matter before the Office of Administrative Hearings. The following 
day, DMHC announced in a press release that the agreement with Anthem involved the plan’s 
processes for identifying and addressing enrollee grievances and appeals. Anthem Blue Cross 
agreed to pay a $2.8 million fine and entered into a Corrective Action Plan (CAP) with DMHC so 
that when an enrollee call reaches a plan customer services representative, it will be categorized 
as a “grievance” rather than an “inquiry.” DMHC took enforcement action against Anthem in 2017 
related to this issue [23:2 CRLR 21–22], and the plan has invested $8.4 million to make 
improvements to its grievances and appeals process. In the enforcement action, DMHC asserted 
that Anthem misclassified grievances as inquiries, denied enrollees their legal right to engage in 
the plan’s and DMHC’s grievance resolution process, and potentially resulted in delays or denials 
of care to enrollees.  
Task Force on Pharmacy Benefit Management 
Reporting 
On June 28, 2019, DMHC announced the development of its Task Force on Pharmacy 
Benefit Management Reporting as required by AB 315 (Wood) (Chapter 905, Statutes of 2018). 
In response to the continued rise of pharmaceutical drug costs, Assembly member Jim Wood (D-
Santa Rosa) authored AB 315 “to open the ‘black box’ of how pharmacy benefit managers operate 
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so that we can better understand their business model, how discounts and rebates are allocated, 
and who benefits. I look forward to the task force helping us ensure that PBMs are doing what’s 
in the best interest of patients, not increasing the PBM’s bottom line.” [24:1 CRLR 38–40] The 
Task Force’s purpose is to recommend what information, if any, related to pharmaceutical costs 
health care service plans or their contracted pharmacy benefit managers should report to DMHC. 
AB 315 requires the Task Force to consider wholesale acquisition costs of pharmaceuticals; rebates 
obtained by the health care service plan or the pharmacy benefit manager from pharmaceutical 
manufacturers; payments to network pharmacies; exclusivity arrangements between health care 
service plans or contracted pharmacy benefit managers with pharmaceutical manufacturers; and 
information already reported by health plans related to the costs of covered prescription drugs as 
required by SB 17 (Hernandez) (Chapter 603, Statutes of 2017). The Task Force held its first 
meeting on July 31, 2019 in Sacramento, and all meetings are open to the public. DMHC will 
submit a report with the Task Force’s recommendations to the legislature by February 1, 2020. 
 Financial Solvency Standards Board Update, July 
2019 Meeting  
On July 17, 2019, the Financial Solvency Standards Board (FSSB) met in Sacramento. The 
agenda covered mid-year updates related to the Department of Health Care Services, regulations, 
federal activities, the Task Force on Pharmacy Benefit Management, provider solvency, and health 
plans. Director Rouillard discussed two mergers that DMHC is reviewing and analyzing in the 
context of AB 595 (Wood) (Chapter 292, Statutes of 2018), which requires DMHC to make a 
determination as to whether a merger is a “major transaction,” triggering a public meeting and 
independent analysis of the market impact of the transaction. The first large national merger 
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involves Centene, a St. Louis-based parent corporation of several large health plan entities 
including Health Net of California, purchasing WellCare, a Florida-based Medicare-focused health 
plan. The second merger involves Anthem acquiring Beacon Health Options, Inc., which is the 
largest privately held behavioral health organization in the nation.  
Highlights from the meeting included a budget presentation, which for fiscal year 2019–
2020 is $91 million in spending authority and 482 authorized positions, an increase of $7 million 
over the prior year and 31 additional positions. The FSSB was briefed on the Integrated Healthcare 
Association’s California Regional Health Care Cost & Quality Atlas program, whose mission is 
to create breakthrough improvements in health care services for Californians through collaboration 
among key stakeholders. Last, Director Rouillard announced that member Jeff Conklin had 
resigned from the FSSB. The next meeting is set to be held on November 17, 2019 
DMHC Rulemaking 
The following are status updates on recent rulemaking proceedings that DMHC has 
initiated, some of which were covered in more detail in Volume 24, Number 2 and Volume 24, 
Number 1 of the California Regulatory Law Reporter [24:2 CRLR 13–16][24:1 CRLR 20–26]: 
⧫ Standard Prescription Drug Formulary Template. On June 25, 2019, OAL approved 
DMHC’s adoption of section 1300.67.205, Title 28 of the CCR. DMHC originally noticed this 
regulation, the Standard Prescription Drug Formulary Template, in September 2018. According to 
the initial statement of reasons, this regulation was DMHC’s effort to implement SB 1052 (Torres) 
(Chapter 575, Statutes of 2014), and was meant to “promote accessibility and transparency in 
prescription drug coverage” and provide “easy access to clear and comparable prescription drug 
information for health plan enrollees.” The changes became effective on October 1, 2019. 
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⧫ Cancellations, Rescissions, and Non-Renewals. On May 10, 2019, DMHC released its 
Notice of Fourth Comment Period with respect to DMHC’s intent to repeal sections 1300.65, 
1300.65.1, 1300.65.2 and add sections 1300.65, 1300.65.1, 1300.65.2, 1300.65.3, 1300.65.4, 
1300.65.5 to Title 28 of the CCR, regarding limitations on the cancellation, rescission, and 
nonrenewal of health care service plan contracts, consistent with federal law under the Patient 
Protection and Affordable Care Act (PPACA). The modified text results from information received 
during the third public comment period, which ended on March 15, 2019. [24:2 CRLR 22–23].  
The newly revised text further clarifies language used throughout the regulation and 
provides greater consistency of terms. For instance, one concern related to section 1300.65.3, 
which defines requirements for the suspension of coverage of an enrollee in the individual market 
who is currently a recipient of advance payments of the premium tax credit (“APTC”) pursuant to 
the federal Patient Protection and Affordable Care Act (“PPACA”), called an “APTC Enrollee.” 
The new rule specifies that a qualified health plan may not take or threaten action that causes or 
suggests that an APTC enrollee’s coverage may be suspended.  
The comment period ended on May 28, 2019. On July 30, 2019, OAL approved the final 
text of the regulation.  
⧫ Financial Solvency of Risk Bearing Organizations. On July 10, 2019, OAL approved 
DMHC’s proposed amendments to sections 1300.75.4, 1300.75.4.1, 1300.75.4.2, 1300.75.4.5, 
1300.75.4.7, 1300.75.4.8, and 1300.76, Title 28 of the CCR. DMHC originally noticed this 
regulation, Financial Solvency of Risk Bearing Organizations, in May 2018. [24:1 CRLR 23–25]. 
According to the initial statement of reasons, this regulation is meant to “implement, interpret and 
make specific the rights and requirements under Health and Safety Code section 1375.4.” These 
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amendments allow DMHC to clarify the definition of a risk bearing organization and how these 
organizations are financially capable of taking on the weight of their risk-based agreements to 
provide health care services to health plan enrollees. The changes became effective on October 1, 
2019. 
LEGISLATION 
AB 290 Wood, as amended September 5, 2019 and as it relates to DMHC, adds sections 
1210, 1367.016, and 1385.09 to the Health and Safety Code to establish requirements related to 
third-party premium payments to health care plans made on behalf of patients by financially 
interested entities or providers. It also defines “financially interested” to include a chronic dialysis 
clinic that is operated, owned, or controlled by a parent entity or related entity that meets the 
definition of a large dialysis clinic organization. According to the author, this bill ends the practice 
where companies that provide certain types of care, e.g., a dialysis company, donate money to a 
nonprofit that, in turn, pays for a patient's private coverage even though they qualify for coverage 
under Medicare or Medi-Cal, in order to receive a higher reimbursement rate. This bill will still 
allow providers, like dialysis companies, to donate to nonprofit organizations if they want to help 
provide premium assistance to patients, but it will not allow them to leverage those donations into 
higher reimbursement rates.  
Governor Newsom signed AB 290 on October 13, 2019 (Chapter 862, Statutes of 2019). 
AB 577 (Eggman), as amended August 14, 2019 and as it relates to DMHC, amends 
section 1373.96 of the Health and Safety Code to extend the duration of the requirement that health 
plans provide continuity of care for pregnant women to up to twelve months from the diagnosis or 
from the end of pregnancy, whichever occurs later, if the woman presents written documentation 
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of being diagnosed with a maternal mental health condition from the individual's treating health 
care provider. According to the author, maternal mental health conditions have impacts far beyond 
the mothers that are experiencing them; they also effect the well-being of children, families, and 
communities. Extending the duration of continuity of care for pregnant women with a maternal 
mental health condition who have had to switch health coverage plans and extending full scope 
Medi-Cal benefits for undocumented pregnant women will ensure that they receive important 
pregnancy-related and post-partum health care, including mental health care. 
Governor Newsom signed AB 577 on October 12, 2019 (Chapter 776, Statutes of 2019). 
AB 651 (Grayson), as amended September 9, 2019 and as it relates to DMHC, amends 
section 1371.55 to the Health and Safety Code to require a health insurance plan issued, amended, 
or renewed on or after January 1, 2020, to provide that if an individual receives covered services 
from a noncontracting air ambulance provider, the individual shall pay no more than the same cost 
sharing that the individual would pay for the same covered services received from a contracting 
air ambulance provider, referred to as the in-network cost-sharing amount. The bill provides that 
an individual would not owe the noncontracting provider more than the in-network cost-sharing 
amount for services. The bill also specifies the processes for advancing unpaid bills to collections 
and for resolving billing disputes.  
Governor Newsom signed AB 651 on October 7, 2019 (Chapter 537, Statutes of 2019). 
AB 731 (Kalra), as amended August 30, 2019 and as it relates to DMHC, amends sections 
1374.21, 1385.01, 1385.02, 1385.045, and 1385.07 of, amends, repeals, and adds section 1385.03 
of, and adds section 1385.046 to, the Health and Safety Code to expand, beginning July 1, 2020, 
rate filing requirements to apply to large group health insurance plans, and imposes additional rate 
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filing requirements on large group contracts and policies. This bill requires a health plan to disclose 
specified information in a rate filing by geographic region for individual, grandfathered group, and no-
grandfathered group contracts and policies, including the price paid compared to the price paid by the 
Medicare program for the same services in each benefit category. DMHC is required to determine if 
large group community rate changes are unreasonable or unjustified, and if so, requires health plans to 
notify the purchaser of an unreasonable or unjustified rate determination. According to the author, 
there needs to be a review from regulators to ensure premium rate increases are reasonable or justified 
in order to curb the skyrocketing cost of health care, which is contributing to wage stagnation and 
fueling income inequality. 
Governor Newsom signed AB 731 on October 12, 2019 (Chapter 807, Statutes of 2019). 
AB 744 (Agular-Curry), as amended September 10, 2019 and as it relates to DMHC, 
amends section 1374.13 of, and adds section 1374.14 to the Health and Safety Code so that 
effective January 1, 2021, health insurance plans reimburse treating or consulting health care 
providers who utilize telehealth to diagnose, consult, or treat a consumer to the same extent as in-
person services. According to the author, “telehealth overcomes access and cost barriers by 
utilizing technology to connect patients to their physicians, no matter where they are located. 
Telehealth uses physicians’ time and expertise more efficiently, while also improving access to all 
types of care for Californians. In particular, expanding access to specialty and behavioral 
healthcare can significantly improve health outcomes for those who currently lack providers.” A 
University of California San Francisco report entitled “A Path to Universal Coverage and Unified 
Health Care Financing in California,” recommends that California encourage greater use of 
telehealth by reimbursing providers for telehealth visits, since most telehealth services are not 
covered under insurance.  
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Governor Newsom signed AB 744 on October 13, 2019 (Chapter 867, Statutes of 2019). 
AB 954 (Wood), as amended July 1, 2019, as it relates to DMHC, adds section 1374.193 
to the Health and Safety Code to authorize a health plan that covers dental services to grant third-
party access to a provider network contract if specified circumstances are met, such as a 
notification to the health care provider about the third-party access and allowing the provider to 
choose not to participate in third-party access to the provider network contract. According to the 
author, network leasing arrangements present numerous problems for dentists and their patients 
because plans that lease or purchase networks do not have any responsibility to be transparent 
about which fee schedules are in effect for their patients. 
Governor Newsom signed AB 954 on October 7, 2019 (Chapter 540, Statutes of 2019). 
AB 1309 (Bauer-Kahan), as amended August 22, 2019 and as it relates to DMHC, adds 
section 1399.848 to the Health and Safety Code to give consumers additional time to sign up for 
health care coverage. This bill specifically states that a health insurer offering policies outside of 
the California Health Benefit Exchange (Exchange) must provide an annual enrollment period for 
policy years beginning on or after January 1, 2020, from November 1 of the preceding calendar 
year, to January 31 of the benefit year. For policy years beginning on or after January 1, 2020, a 
health insurer offering policies through the Exchange must provide a special enrollment period 
from December 16 of the preceding calendar year, through January 31 of the benefit year. An 
application for a health benefit plan submitted during this special enrollment period is to be treated 
the same as an application submitted during the annual open enrollment period. 
Governor Newsom signed AB 1309 on October 12, 2019 (Chapter 828, Statutes of 2019). 
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AB 1622 (Carrillo), as amended September 6, 2019 and as it relates to DMHC, amends 
sections 1339.7, 1367.695, 101560, 123515, 127900, 128205, and 151001 of the Health and Safety 
Code to apply the “family physician” definition to provisions of relevant statute. Specifically, 
when policyholders seek obstetrical and gynecological physician services, they may do so directly 
from an obstetrician and gynecologist or directly from a participating family physician and surgeon 
designated by the plan as providing obstetrical and gynecological services. The bill refers to an 
individual who practices family medicine as a family physician and surgeon, and would make 
technical, conforming, and non-substantive changes. According to the author, family medicine 
encourages continuity of care and improved patient outcomes, and this bill allows family 
physicians to work in a capacity that reflects their training and expertise. 
Governor Newsom signed AB 1622 on October 8, 2019 (Chapter 632, Statutes of 2019). 
AB 1802 (Committee on Health), as amended April 11, 2019, amends sections 1358.20, 
1368.015, 1368.02, 1371, and 1373.65 of the Health and Safety Code to clarify that the obligation 
of a health plan to comply with claims reimbursement obligations is not deemed to be waived if 
the plan requires its medical groups, independent practice associations, or other contracting entities 
to pay claims for covered services. According to the Committee on Health, this bill reverts 
language back to its original statutory language to apply to all health plans and updates DMHC 
telephone and internet website addresses in specified materials.  
Governor Newsom signed AB 1802 on July 12, 2019 (Chapter 113, Statutes of 2019).  
SB 129 (Pan), as amended June 12, 2019, amends section 1348.95 of the Health and Safety 
Code to require annual health plan and insurer enrollment reporting to include enrollment data for 
products sold inside and outside of Covered California, any other business lines, and multiple 
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employer welfare arrangements. It also requires DMHC to publicly report annual enrollment data 
by April 15th of every year. According to the author, since the enactment of the Affordable Care 
Act, the health care market has undergone major transformation, as California’s uninsured rate has 
been dramatically reduced and millions of individuals have gained coverage in the Medi-Cal 
program and individual and small group markets. Beginning in 2013, California tracked 
enrollment in different types of health care coverage products and business lines. This information 
helped policymakers monitor trends over time. This bill is necessary to update the insurer 
enrollment reporting requirement to capture additional business lines and ensure the annual 
availability of the data collected.  
Governor Newsom signed SB 129 on September 5, 2019 (Chapter 241, Statutes of 2019). 
SB 159 (Wiener), as amended September 5, 2019, amends section 1342 and adds section 
1342.74 to the Health and Safety Code to prohibit a health insurer from subjecting antiretroviral 
drugs that are medically necessary for the prevention of AIDS/HIV, including preexposure 
prophylaxis or postexposure prophylaxis, to prior authorization or step therapy. Under the bill, 
notwithstanding any other law, a health insurer shall not prohibit, or permit a contracted pharmacy 
benefit manager to prohibit, a pharmacist from dispensing preexposure prophylaxis or 
postexposure prophylaxis. According to the author, data indicate that allowing access to these 
drugs only with a physician’s prescription is blocking access for individuals who would benefit 
most. 
Governor Newsom signed SB 159 on October 7, 2019 (Chapter 532, Statutes of 2019). 
SB 343 (Pan), as amended August 12, 2019, amends sections 1385.03, 1385.045, 1385.07, 
128735, 128740, and 128760 of the Health and Safety Code to require large health insurance 
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policies and insurers to file with DMHC the weighted average rate increase for all large group 
benefit designs during a twelve-month period. This bill eliminates alternative reporting 
requirements for plans or insurers that have no more than two medical groups or a health facility 
that receives the majority of its revenue from prepayment health care service plans, e.g., Kaiser 
Permanente. This bill results in all health care service plans reporting the same information and 
being held to the same standards as large health insurance plans.  
Governor Newsom signed AB 343 on September 5, 2019 (Chapter 247, Statutes of 2019). 
SB 407 (Monning), as amended September 5, 2019, amends sections 1358.91 and 1358.11 
of the Health and Safety Code to require an issuer of a Medicare supplement contract with new or 
innovative benefits commencing January 1, 2020, to identify the portion of the premium attributed 
to a new or innovative benefit as a separate line item on the payment or invoice and extends the 
Medicare supplement open enrollment period to a minimum of 60 days. This bill also requires a 
Medicare supplement policy, certificate, or contract issuer to notify an enrollee of their open 
enrollment rights on any notice related to a benefit modification or premium adjustment. 
Additionally, DMHC must collaborate with the Department of Insurance to develop and 
implement policies and procedures that standardize new or innovative benefits for purposes of 
allowing consumer comparison of benefits, out-of-pocket costs, and premiums. According to the 
author, this bill sets consumer-focused standards, which protect and allow seniors to fully 
understand all aspects of an innovative plan they may purchase. 
Governor Newsom signed SB 407 on October 7, 2019 (Chapter 549, Statutes of 2019).  
SB 600 (Portantino), as amended September 5, 2019, adds section 1374.551 to the Health 
and Safety Code to require that standard fertility preservation services are covered as basic health 
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services when a covered treatment may directly or indirectly cause iatrogenic infertility, with the 
exemption of Medi-Cal managed care plans and clarifying that these services are basic health care 
services with respect to health plans. New section 1374.551 defines “iatrogenic infertility” to mean 
infertility caused directly or indirectly by surgery, chemotherapy, radiation, or other medical 
treatment.  
Governor Newsom signed SB 600 on October 12, 2019 (Chapter 853, Statutes of 2019). 
SB 714 (Pan), as amended September 6, 2019, amends sections 120370, 120372, and 
120372.05 of the Health and Safety Code to allow a child who has a medical exemption for certain 
vaccinations issued before January 1, 2020, to be allowed to continue enrollment until the child 
enrolls in the next grade span. This bill prohibits, on and after July 1, 2021, a governing authority 
from unconditionally admitting or readmitting to these institutions, or admitting or advancing any 
pupil to 7th grade level, unless the pupil has been immunized or has a medical exemption through 
a procedure that includes the completion of a compliant statewide form. The bill removes the 
requirement that the statewide form be signed under penalty of perjury by an eligible physician or 
surgeon, and specifies which physicians and surgeons are eligible to issue a medical exemption. 
According to the author, SB 714 provides technical revisions necessary for the Department of 
Public Health to implement SB 276 (Pan) (Chapter 278, Statutes of 2019). 
Governor Newsom signed SB 714 on September 9, 2019 (Chapter 281, Statutes of 2019). 
SB 784 (Committee on Health), as amended June 3, 2019 and as it applies to DMHC, 
amends sections 1358.91 and 1358.11 of, and adds sections 1358.92 to, the Health and Safety 
Code to make conforming changes in California law to the requirements and standards that apply 
to Medicare supplement contracts and policies, for the purpose of complying with the federal 
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Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). Specifically, the bill amends 
section 1358.91 to clarify that, effective January 1, 2020, the standardized Medicare supplement 
benefit plan D can now also be offered to any individual who was eligible for Medicare prior to 
the effective date. Amended section 1358.11 requires that for all contracts sold or issued on or 
after January 1, 2020, the issuer shall offer new Medicare beneficiaries additional Medicare 
supplement benefit plan options if the applicant’s original supplement is unavailable. According 
to the author, the policy changes need to be in place prior to the 2020 plan year so this bill contains 
an urgency clause.  
Governor Newsom signed SB 784 on July 30, 2019 (Chapter 157, Statutes of 2019). Due 
to the urgency clause the bill became effective immediately. 
AB 993 (Nazarian), as amended September 4, 2019, would have added section 1367.693 
to the Health and Safety Code to allow patients to designate HIV specialists as eligible primary 
care physicians. According to the author, by allowing HIV specialists to serve as primary care 
providers for their patients, this bill eliminates administrative impediments, such as ordering tests 
or making additional referrals, maintains continuity of care for a disease that has become 
manageable today, and protects the patient against unintentionally errant treatment.  
Governor Newsom vetoed AB 993 on October 12, 2019 stating that the bill was 
unnecessary because existing law already permits specialists to serve as primary care physicians.  
AB 1249 (Maienschein), as amended August 30, 2019, would have added and repealed 
section 1343.3 to the Health and Safety Code, to require the DMHC Director, by May 1, 2020, to 
authorize two pilot programs, one in northern California and one in southern California to 
demonstrate the control of costs for health care services and the improvement of health outcomes 
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and quality of service when compared against a sole fee-for-service provider reimbursement 
model. Each pilot program would have been conducted under the voluntary employees’ 
beneficiary association (VEBA) with more than 100,000 enrollees. The bill would have required 
each health care provider participating in a pilot program to report to DMHC with information on 
cost savings and clinical patient outcomes. New section 1343.3 would have required the DMHC 
to report those findings to the legislature by June 1, 2026.  
On September 27, 2019, Governor Newsom vetoed AB 1249, stating that “this bill would 
authorize a pilot program that would exempt risk-bearing provider groups taking on global risk 
from full licensure under the Knox-Keene Act. This proposed pilot project would undermine the 
fundamental purpose of the Knox-Keene Act by permitting such entities to operate in the State 
without providing the strong consumer protections guaranteed under the Act.” 
SB 382 (Neilsen), as amended on September 3, 2019, would have added section 14197.6 
to the Welfare and Institutions Code to require Medi-Cal managed care health plans (MCPs) to 
ensure that members who remain in a general acute care hospital continue to receive medically 
necessary post-acute care services at the general acute care hospital, during a Governor-declared 
state of emergency, if specified requirements are met.  
On October 12, 2019, Governor Newsom vetoed SB 382 stating, “[w]hile the intent of this 
bill to ensure the MCP members who are impacted by an emergency continue to receive medically 
necessary care is admirable, it is also unnecessary...[t]o the extent that there are scenarios where a 
MCP has not appropriately reimbursed a general acute care hospital, I encourage the Legislature 
to work with my administration to address any such issues.” 
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Legislative Bills That Died 
The following bills reported in Volume 24, No. 2 (Spring 2019) died in committee or 
otherwise failed to be enacted during 2019: AB 598 (Bloom), which would have required a health 
care plan to include coverage for hearing aids for an enrollee under 18 years of age; AB 648 
(Nazarian), which would have established rules that govern wellness programs instituted by health 
plans, insurers and employers such as prohibiting an employer from requiring an employee to 
participate in a wellness program as a condition of employment; AB 767 (Wicks), which would 
have required Covered California to develop options for the inclusion of in vitro fertilization 
coverage as part of, or as supplementary to, coverage currently offered through Covered 
California; AB 1174 (Wood), which would have required health plans to have contracts in place 
with anesthesia providers and ensure enrollees could access a contracted anesthesia provider; 
AB 1268 (Rodriguez), which would have required entities that perform utilization review or 
utilization management functions to report the number of services denied or approved. It also 
would have required plans to report the information to DMHC to determine compliance with 
existing law; AB 1656 (Gallagher), which would have clarified that a physician or authorized 
hospital staff may administer or dispense narcotic drugs in a hospital to maintain or detoxify a 
person incidental to medical or surgical treatment of conditions other than addiction; AB 1670 
(Holden), which would have authorized a provider that contracts with a health plan to bill an 
enrollee for a service that is not a covered benefit if the enrollee consents in writing and that written 
consent meets specified criteria; AB 1676 (Maienschein), which would have required health plans, 
by January 1, 2021, to establish a telehealth consultation program that allowed providers who treat 
children and pregnant and postpartum persons access to a psychiatrist during standard provider 
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hours; SB 11 (Beall), which would have required health plans that provide prescription drug 
benefits for the treatment of substance use disorders to place prescription medications approved 
by the federal Food and Drug Administration (FDA) for the treatment of substance use disorders 
on the lowest cost-sharing tier of the plan’s prescription drug formulary; SB 163 (Garcia), which 
would have required the California Department of Social Services to create a facilities liaison 
position within its Immigration Services Unit to assist state-licensed resource facilities that service 
undocumented immigrant youth in connecting with appropriate supports and services; SB 406 
(Pan), which would have rewritten existing law that requires health plans to cover preventive 
services without cost sharing by deleting federal statutory citations and replacing those citations 
with the actual federal provisions that impose the requirements; SB 612 (Pan), which would have 
required a health plan to report on its participation in specified collaboratives and activities, 
including whether the supportive and therapeutic needs of an enrollee are addressed in a holistic 
fashion, to the Office of Statewide Health Planning and Development (OSHPD), and would have 
required OSHPD to compile and publish the information on its website; and SB 746 (Bates), which 
would have required health plans to cover medically necessary anti-cancer medical devices 
designed for use outside of a medical treatment facility. 
LITIGATION 
⧫ Pharmaceutical Research & Manufacturers of America v. Brown, Case No. 2:17-cv-
02573-MCE-KJN (E.D. Cal.). On July 31st, 2019, District Judge Morrison C. England, Jr. denied 
Defendant California’s Motion to Dismiss and granted Defendant’s Request for Judicial Notice. 
As reported previously, on September 28, 2018, Plaintiff PhRMA submitted its first amended 
complaint alleging that SB 17 (Hernandez) (Chapter 603, Statutes of 2017) is unconstitutional in 
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that it compels them to speak about potential price increases when they would prefer not to 
communicate that information (thus violating these corporation’s asserted first amendment rights); 
additionally, PhRMA alleges that the bill interferes with interstate commerce. In its prayer for 
relief, PhRMA seeks an injunction to prevent California from implementing and enforcing SB 17, 
and a declaration that the statute is unconstitutional due to its various notice, reporting, and 
justification obligations for prescription drug manufacturers. [24:1 CRLR 44–45]  
⧫ Missionary Guadalupanas of Holy Spirit Inc. v. Rouillard, Case No. C083232 (Cal. 
App.). On August 6, 2019, Judge Blease of the Third Appellate District Court of California upheld 
the trial court’s judgment finding that Michelle Rouillard, Director of DMHC, did not violate the 
Administrative Procedure Act by directing seven health plans to comply with California law in 
their coverage of abortion services. The issue in this case was whether a “voluntary” abortion is a 
“medically necessary” procedure that health plans are required to cover. Judge Blease held that the 
appellant, Missionary Guadalupanas of the Holy Spirit, Inc., “attempt[ed] to limit coverage of most 
abortions by health care service plans in California” by “setting up a false choice between 
‘voluntary’ and ‘medically necessary’ abortions.” 
Judge Blease found that “medically necessary” covers not only lifesaving treatments, but 
women’s reproductive health, and recognized that abortion is “both a recognized treatment for the 
medical condition of a patient’s pregnancy, and a treatment every woman in California has the 
legal right to choose.” Furthermore, abortion services are included in “basic health care services” 
under Health and Safety Code section 1345(b), and the California Constitution prohibits health 
plans from discriminating against women who choose to terminate a pregnancy.  
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On October 4, 2019 Plaintiff-Appellants filed a petition for review with the Supreme Court 
Case No. S258380.  
⧫ Association of American Physicians & Surgeons, Inc. v. Rouillard, Case No. No. 2:16-
cv-02441-MCE-EFB (E.D. Cal.). On June 13, 2019, District Court Judge Morrison C. England 
Jr. granted Defendant’s motion to dismiss this litigation for failure to state a claim, holding that 
the plaintiffs failed to allege requisite standing to pursue claims; failed to plead a property interest 
deprivation for a due process claim; even if plaintiffs had pleaded a property interest deprivation, 
they failed to allege that they were denied due process; and also, plaintiffs failed to state a takings 
claim. The Judge granted this motion but allowed plaintiffs one last attempt to properly assert a 
claim in the form of an amended complaint. 
This case involves AB 72 (Bonta) (Chapter 492, Statutes of 2016), which adds several new 
sections to the Health and Safety Code and the Insurance Code to limit the rights of reimbursement 
for out-of-network physicians. The change in law, effective July 1, 2017, requires the following 
for out-of-network physicians: 
[U]nless otherwise agreed to by the noncontracting individual health professional 
and the plan, the plan shall reimburse the greater of the average contracted rate or 
125 percent of the amount Medicare reimburses on a fee-for-service basis for the 
same or similar services in the general geographic region in which the services were 
rendered. For the purposes of this section, “average contracted rate” means the 
average of the contracted commercial rates paid by the health plan or delegated 
entity for the same or similar services in the geographic region.  
AB 72, section 2 (adding section 1371.31 to the Health and Safety Code). According to 
plaintiffs, the effective of the change in law prohibits an out-of-network physician from 
recovering fully on his or her claims for services lawfully rendered.  
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The District Court held, however, that the plaintiffs failed to establish an injury, or 
imminent harm to find standing when it stated, “[n]oticeably absent, however, are any 
allegations addressing the Court's concerns, as set forth in its prior Order, that Plaintiffs 
need to allege facts demonstrating: ‘(1) the inability of out-of-network providers to reach 
agreements for reasonable compensation with health care service plans; (2) the setting of 
unreasonable rates of reimbursement; and (3) unsuccessful appeals pursuant to AB 72's 
independent dispute resolution process.’” In essence, plaintiffs failed to set forth any facts 
creating a nexus between their assertions and any provision of the Act, leaving their claims 
“speculative at best.” Furthermore, even if standing was found, the Judge states that the 
plaintiffs do not currently have a valid takings or preemption claim, due to the lack of 
causality.  
It is for these reasons that Defendant's Motion to Dismiss was granted with one 
final leave to amend, that was to be submitted no later than thirty (30) days following the 
date of the Order, filed June 14, 2019. On August 21, 2019, Judge England dismissed this 
action without prejudice in its entirety. 
⧫ Children’s Hospital Association of Texas, et al. v. Azar, Case No. No. 1:17-cv-00844 
(D.D.C), Case No. 18-5135 (D.C. Cir.), 933 F.3d 764 (D.C. Cir. 2019). Under the Medicaid Act, 
the federal government provides states with funds to distribute to hospitals that treat a 
disproportionate number of low-income patients. These funds are called Disproportionate Share 
Hospital (DSH) payments. DSH payments may not exceed the “costs incurred” by these hospitals 
in serving low-income patients. In 2017, the Secretary of the U.S. Department of Health and 
Human Services implemented a regulation defining “costs incurred” to mean that the payments 
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made by Medicaid and uninsured people must be subtracted out when calculating a hospital’s 
incurred costs (“2017 Rule”). 82 C.F.R. § 16,114; 16,122 (Apr. 3, 2017). In Children’s Hospital 
Association of Texas v. Azar, the plaintiffs, a group of children’s hospitals that receive DHS 
payments, argued that the regulatory definition of “costs incurred” conflicted with the Medicaid 
Act. The dispute centered on the question of whether payments made by Medicare and private 
insurers should also be subtracted out of DHS payment calculations. The district court agreed with 
the plaintiffs and vacated the 2017 Rule.  
On August 13, 2019, Judge Henderson of the D.C. Circuit Appellate Court reversed the 
district court’s ruling. Judge Henderson held that the 2017 Rule was reasonable because while 
Medicare and private insurers are not specifically mentioned, there is nothing in the Medicaid 
Act’s text that suggests Congress meant for these related sources of income to be excluded. Judge 
Henderson found that the 2017 Rule is 
consistent with the statute’s context and purpose, both of which suggest DSH 
payments are meant to assist those hospitals that need them most by covering only 
those costs for which DSH hospitals are in fact uncompensated. …By requiring the 
inclusion of payments by Medicare and private insurers, the 2017 Rule ensures that 
DSH payments will go to hospitals that have been compensated least and are thus 
most in need. 
933 F.3d 764, 772. The 2017 Rule is therefore consistent with the Medicaid Act.  
